For the past several years, artificial intelligence has dominated investor conversations. Speed, scale, and access to increasingly powerful foundation models fueled a wave of experimentation and capital deployment across nearly every sector.
But we are now entering a different phase of the AI cycle.
The excitement hasn’t disappeared; it has matured.
As AI capabilities commoditize, investors are quietly recalibrating what actually creates durable advantage. Increasingly, the answer is not better models or faster iteration cycles. It is deep domain expertise embedded directly into the architecture of AI systems.
In other words, context has become the new moat.
From AI Gold Rush to AI Reckoning
The first wave of AI investing rewarded novelty and velocity. If a company could demonstrate technical competence, rapid prototyping, and access to cutting-edge models, it often attracted attention…and capital.
That environment has changed.
Foundation models are now broadly accessible. Infrastructure costs are falling. “AI-powered” has become table stakes rather than differentiation. As one investor succinctly put it:
“Models are no longer scarce. Judgment is.”
This shift has forced investors to ask harder questions:
Why Many AI Startups Stall After the Demo
Across sectors, a consistent pattern has emerged: many AI startups struggle not because their technology is weak, but because their understanding of the domain is shallow.
Common failure modes include:
As Andreessen Horowitz has noted in multiple AI and healthcare theses, the most dangerous failures occur when software teams attempt to “AI-ify” industries they do not fully understand.
“The next generation of enduring AI companies will be built by people who deeply understand the workflows, incentives, and constraints of the industries they are transforming.”
— Andreessen Horowitz, AI + Healthcare Thesis
AI amplifies whatever understanding is encoded into it. When that understanding is incomplete, the system simply scales mistakes faster.
The Investor Shift: Domain Expertise as a Risk Filter
This reality is driving a quiet but decisive shift in how sophisticated investors evaluate AI opportunities.
Increasingly, investors are prioritizing:
As one repeat founder and advisor recently shared in a closed founder session:
“At this stage, AI competence is assumed. What investors want to know is whether the founder actually understands the problem space well enough not to blow themselves up.”
This is not a rejection of AI innovation. It is an acknowledgment that AI without context introduces systemic risk; particularly in regulated or trust-dependent industries.
The New AI Moat Defined
If models are no longer the moat, what is?
Across leading venture firms, including Sequoia Capital and General Catalyst, a consistent theme has emerged: defensibility now lives at the intersection of domain knowledge, data curation, and governance.
The new AI moat includes:
Sequoia has framed this evolution clearly:
“As AI models commoditize, durable advantage shifts to companies that embed deeply into real workflows and regulated environments.”
— Sequoia Capital, AI Moats Commentary
In short, contextual intelligence outlasts computational advantage.
Why Regulated Industries Accelerate This Shift
Nowhere is this shift more pronounced than in regulated sectors such as healthcare, life sciences, nutrition, and wellness.
In these industries:
General Catalyst has emphasized that AI systems operating in regulated domains must be designed with domain expertise from inception, not retrofitted after market entry.
“AI platforms in healthcare fail when domain expertise is treated as advisory rather than foundational.”
— General Catalyst, Responsible AI in Healthcare
This dynamic is forcing investors to rethink what “technical risk” actually means. In many cases, domain ignorance is the largest technical risk of all.
A Case in Point: Building AI From Inside the Domain
Some of the most resilient AI platforms are being built by founders who did not start with a model; they started with a problem they had lived inside for decades.
In the nutrition and supplement space, this distinction is particularly stark. The industry combines:
Building credible AI in this environment requires more than software talent. It requires deep familiarity with clinical research, regulatory frameworks, ingredient science, and real-world product behavior.
NutriSelect.ai, Inc. was architected from this perspective; not as a generic AI application, but as a domain-embedded intelligence platform informed by decades of industry experience and guided by a seasoned Scientific Advisory Board. AI is not the product; it is the engine enabling structured scientific judgment at scale.
This distinction matters to investors not because it sounds good, but because it compresses execution risk.
What This Means for Long-Term Capital
For investors with long horizons, this shift has important implications.
Domain-embedded AI companies may:
But over time, these companies tend to:
As one experienced investor put it:
“Fast AI companies are exciting. Durable AI companies are rare.”
The Quiet Advantage
As AI becomes ubiquitous, differentiation will no longer come from what can be automated, but from what should not be automated without expert oversight.
The future belongs to AI platforms built by insiders who understand:
In this next phase of AI investing, domain expertise is no longer a bonus.
It is the filter.
And for investors paying attention, it may be the clearest signal of all.
Author’s Note
This perspective reflects broader shifts observed across venture capital, regulated industries, and founder-led AI platforms built for long-term impact rather than short-term novelty.
